Palatin Technologies Inc.
Palatin Technologies Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Palatin Technologies Inc. is a mediocre stock to choose.
Log in to see more information.
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medic...
News
Cosette Pharmaceuticals Acquires Vyleesi (Bremelanotide Injection) from Palatin Technologies Inc.
Business Wire Cosette Pharmaceuticals, Inc. (Cosette), a US-based specialty pharmaceutical company with a focus on womens health and cardiovascular medicines, has completed the acquisition of Vyleesi from Palatin...\n more…